🔎 Trials Near Me

Utama › Gangguan Depresi Major › Florida › Orlando

Kajian klinikal Gangguan Depresi Major di Orlando, FL

19 kajian untuk Gangguan Depresi Major sedang mencari peserta di lokasi dalam dan sekitar Orlando (dalam lingkungan kira-kira 30 batu). Buka kajian untuk melihat siapa yang layak menyertai dan cara menghubungi pasukan kajian.

Teks kajian rasmi (Bahasa Inggeris)

Mengambil peserta untuk kajian di sini? Paparkan di bahagian atas halaman ini — $99 selama 30 hari →

Phase 3 Study of Adjunctive Treatment With Seltorexant in Adult and Elderly Participants With Major Depressive Disorder and Insomnia Symptoms

Mengambil pesertaFasa 3
  • Nova Psychiatry INC, Orlando
Umur 18 hingga 74 · Semua jantina · Dikemas kini 25 Sep 2026 · NCT06559306

A Study to Evaluate TNX-102 SL Monotherapy Versus Placebo in Participants With Major Depressive Disorder (MDD)

Mengambil pesertaFasa 2
  • Clinical Neuroscience Solutions Inc. - Orlando, Orlando
  • K2 Medical Research - Maitland, Maitland · 6 mi jauh
Umur 18 ke atas · Semua jantina · Dikemas kini 25 Sep 2026 · NCT07621237

A Study of a Deuterated Psilocin Analog (CYB003) in Humans With Major Depressive Disorder

Mengambil pesertaFasa 3
  • Accel Research Sites - Maitland, Maitland · 6 mi jauh
Umur 18 hingga 85 · Semua jantina · Dikemas kini 25 Sep 2026 · NCT06793397

A Study to Evaluate the Efficacy and Safety of SPT-300 (GlyphAllo) in Participants With Major Depressive Disorder, With or Without Anxious Distress (BUOY-1 Study)

Mengambil pesertaFasa 2
  • Seaport Investigator Site, Orlando
Umur 18 hingga 65 · Semua jantina · Dikemas kini 14 Sep 2026 · NCT07065240

ACP-211 Monotherapy for Major Depressive Disorder With Inadequate Antidepressant Response

Mengambil pesertaFasa 2
  • Clinical Neuroscience Solutions, Inc., Orlando
Umur 18 hingga 65 · Semua jantina · Dikemas kini 14 Sep 2026 · NCT07284667

A Study to Evaluate the Effectiveness of DT-101 as an Adjunctive Treatment in Patients With Depression

Mengambil pesertaFasa 2
  • Draig Clinical Site, Orlando
  • Draig Clinical Site, Orlando
Umur 18 hingga 75 · Semua jantina · Dikemas kini 2 Sep 2026 · NCT07610473

A Study to Evaluate the Effectiveness of DT-101 in Patients With Depression

Mengambil pesertaFasa 2
  • Draig Clinical Site, Orlando
Umur 18 hingga 75 · Semua jantina · Dikemas kini 26 Ogo 2026 · NCT07300969

A Phase 3 Trial of DT120 for Major Depressive Disorder (Ascend)

Mengambil pesertaFasa 3
  • Clinical Neuroscience Solutions, LLC (Orlando), Orlando
  • Charter Research, Orlando
  • K2 Medical Research (Maitland), Maitland · 6 mi jauh
Umur 18 hingga 74 · Semua jantina · Dikemas kini 10 Ogo 2026 · NCT07592689

NBI-1065845-MDD3026: Study to Assess the Efficacy and Safety of NBI-1065845 as an Adjunctive Treatment in Participants With Major Depressive Disorder (MDD)

Mengambil pesertaFasa 3
  • Neurocrine Clinical Site, Maitland · 6 mi jauh
Umur 18 ke atas · Semua jantina · Dikemas kini 10 Ogo 2026 · NCT06963021

A Study of Brenipatide in Adult Participants With Major Depressive Disorder

Mengambil pesertaFasa 3
  • Charter Research - Orlando, Orlando
  • K2 Medical Research - Maitland, Maitland · 6 mi jauh
Umur 18 hingga 75 · Semua jantina · Dikemas kini 6 Ogo 2026 · NCT07412756

A Randomized Study of Azetukalner Versus Placebo in Major Depressive Disorder

Mengambil pesertaFasa 3
  • Clinical Neuroscience Solutions, Inc., Orlando
Umur 18 hingga 74 · Semua jantina · Dikemas kini 3 Ogo 2026 · NCT06775379

Zelquistinel or Placebo for the Reduction of Symptoms of Major Depressive Disorder

Mengambil pesertaFasa 2
  • Clinical Neuroscience Solutions, Inc., Orlando
Umur 18 hingga 64 · Semua jantina · Dikemas kini 3 Ogo 2026 · NCT06547489

A Study to Evaluate the Maintenance Effect of NBI-1065845 as an Adjunctive Treatment in Participants With Major Depressive Disorder (MDD)

Mengambil pesertaFasa 3
  • Neurocrine Clinical Site, Orlando
Umur 18 ke atas · Semua jantina · Dikemas kini 24 Jul 2026 · NCT07196501

Long-Term Study to Assess the Safety and Tolerability of NBI-1065845 as an Adjunctive Treatment in Participants With Major Depressive Disorder (MDD)

Mengambil pesertaFasa 3
  • Neurocrine Clinical Site, Maitland · 6 mi jauh
  • Neurocrine Clinical Site, Maitland · 6 mi jauh
Umur 18 ke atas · Semua jantina · Dikemas kini 24 Jul 2026 · NCT06966401

A Study to Assess Change in Disease Activity and Adverse Events of Oral Icalcaprant in Adult Participants With Major Depressive Disorder

Mengambil pesertaFasa 2
  • Clinical Neuroscience Solutions - Orlando - East South Street /ID# 277558, Orlando
Umur 18 hingga 65 · Semua jantina · Dikemas kini 15 Jun 2026 · NCT07276997

Study to Assess the Efficacy and Safety of NBI-1065845 as an Adjunctive Treatment in Participants With Major Depressive Disorder (MDD)

Mengambil pesertaFasa 3
  • Neurocrine Clinical Site, Maitland · 6 mi jauh
Umur 18 ke atas · Semua jantina · Dikemas kini 29 Okt 2025 · NCT06786624

Targeting Network Dysfunction in Apathy of Late-life Depression Using Digital Therapeutics

Mengambil peserta
  • AdventHealth Neuroscience Institute, Orlando
Umur 60 ke atas · Semua jantina · Dikemas kini 22 Okt 2025 · NCT05877885

Study of ALTO-300 in MDD

Mengambil pesertaFasa 2
  • Site 159, Clermont · 24 mi jauh
Umur 18 hingga 70 · Semua jantina · Dikemas kini 24 Jul 2025 · NCT05922878

A Study to Evaluate the Efficacy of AXS-05 Compared to Bupropion in Preventing the Relapse of Depressive Symptoms

Mengambil pesertaFasa 4
  • Clinical Research Site, Orlando
  • Clinical Research Site, Orlando
  • Clinical Research Site, Orlando
Umur 18 hingga 65 · Semua jantina · Dikemas kini 23 Jan 2025 · NCT06223880

Kajian Gangguan Depresi Major di bandar lain

Kajian lain di Orlando

Daripada ClinicalTrials.gov, data diperoleh pada 5 Okt 2026. Setiap kajian menetapkan kriteria kelayakannya sendiri; pasukan kajian menentukan siapa yang layak menyertai.